Dan Beacon – Ataxia

Dan Beacon

Omaveloxolone (Omav) Update

In October 2019, Reata Pharmaceuticals announced positive top-line results from their MOXIe trial testing Omaveloxolone (or Omav) in Friedreich’s ataxia (FA). In the MOXIe trial, Reata used the modified Friedreich’s Ataxia Rating Scale (mFARS) to measure the symptoms of those taking Omav vs those taking placebo (a placebo is a substance that has no therapeutic …

Omaveloxolone (Omav) Update Read More »

Helpful resources

Mental health and wellbeing Talking to children about illness NHS Living Life is a free and confidential telephone counselling service based on a Cognitive Behavioural Therapy approach. The service is available to anyone over the age of 16 suffering low mood, mild to moderate depression and/or anxiety. The service can be accessed by referral from a …

Helpful resources Read More »

Donate Now
Welcome to our new site! We hope you like it.
As it's brand new, there may be a few temporary glitches such as broken links - we are working on getting these all fixed ASAP. If you'd like to give us any feedback or let us know if something isn't quite right, please email website@ataxia.org.uk
Scroll to Top